GlaxoSmithKline to spin-off £30 billion consumer healthcare arm in 2022
Global pharmaceutical company GlaxoSmithKline (GSK) plans to demerge its consumer healthcare division by August 2022 and give investors a direct stake in the some of the world's most iconic consumer brands.While details are still...
17 June 2021
